Ушбу ишга иқтибос қилган ишлар

5 та иш

Иш: Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS/MS and its application in the clinical determination in patients with tumors associated with overactive bladder

1. Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms

   Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4

   МақолаProtein Degradation and InhibitorsBiomolecules20262 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000038

2. Investigation of the detection of Thioguanine anti-cancer drug by using of X12O12 (X = mg, Zn) nanocage

   Mustafa Habeeb Chyad, Abdulrahman T. Ahmed, Gaurav Sanghvi +7

   МақолаElectrochemical sensors and biosensorsComputational and Theoretical Chemistry20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.005126

3. Pharmacomicrobiomics in blood cancers: How the gut microbiome and its metabolites shape drug efficacy and toxicity

   Chou-Yi Hsu, Yasir Qasim Almajidi, Mohammad Abohassan +7

   МақолаGut microbiota and healthCritical Reviews in Oncology/Hematology20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.000310

4. The microbial metabolome: remodeling the therapeutic landscape in hematologic malignancies

   Liang Zhang, Hamed Soleimani Samarkhazan, Yaseer almajidi +1

   МақолаGut microbiota and healthnpj Biofilms and Microbiomes20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.013223

5. Nanomedicine to enhance melanoma radiotherapy: Mechanisms and translational prospects

   Chou-Yi Hsu, Jasur Rizaev, Saleh A. S. AlAbdulhadi +5

   МақолаRadiation Therapy and DosimetryJournal of Pharmacology and Experimental Therapeutics20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.013977